中文名：（R）-8-（3-氨基哌啶-1-基）-7-（丁-2-炔基）-3-甲基-1  - （（4-甲基喹唑啉-2-基）甲基）-1H-嘌呤-2-，6（3H，7H） - 二酮；CS-494;利那列汀;利拉列汀;利格列汀;利拉利汀原料藥;利納利汀;利拉利汀/利格列汀/;CS-1974；

英文名：(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione；Tradjenta;Linagliptin-D4;Linagliptin (BI-1356);Linaglitine;(R)-8-(3-aMinopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;Linagliptin API;1H-Purine-2,6-dione,8-[(3R)-3-aMino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-;(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

類別：原料藥;醫(yī)藥中間體;其他雜環(huán);醫(yī)藥原料;利拉利汀;現(xiàn)貨;小分子抑制劑;醫(yī)藥原料藥;蛋白酶;醫(yī)藥 抑制劑;對(duì)照品-雜質(zhì)對(duì)照品;中間體-;醫(yī)藥原料-;醫(yī)藥中間體，醫(yī)藥原料，精細(xì)化工品。;對(duì)照品-;原料藥-;Pharmaceutical raw material;Inhibitor;Linagliptin;-;TRADJENTA;Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;API